Home > Healthcare > Pharmaceuticals > Finished Drug Form > Oxycodone Drugs Market

Oxycodone Drugs Market Share

Report ID: GMI9228
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Oxycodone Drugs Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical companies that involved in the manufacturing of opioid containing pain management drugs vying for market share. Key players are engaging in strategic initiatives such as collaboration, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for oxycodone drugs.

Oxycodone Drugs Market Companies

Prominent players operating in the oxycodone drugs industry are as mentioned below:

Alvogen
Ani Pharmaceuticals, Inc.
Daiichi Sankyo Company Ltd.
Endo Pharmaceuticals
Mallinckrodt Pharmaceuticals
Mylan N.V.
Protega Pharmaceuticals LLC
Purdue Pharma LP
Quagen Pharma
Teva Pharmaceuticals, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oxycodone drugs industry size was USD 5.4 billion in 2023 and is projected to showcase 5.7% CAGR from 2024 to 2032, owing to the rise in incidence of chronic pain diseases like cancer, neuropathic disease, and musculoskeletal disorders.

The long-acting oxycodone segment in the market reached USD 3.4 billion in 2023 and is estimated to grow at substantial CAGR between 2024 and 2032, due to their convenience of less frequent dosing.

North America oxycodone drugs industry accumulated 42.7% revenue share in 2023 and is predicted to grow at notable rate between 2024 and 2032, owing to the increase in incidence of cancer and the rising trend of drug prescription to manage cancer-related pain.

Alvogen, Ani Pharmaceuticals, Inc., Daiichi Sankyo Company Ltd., Endo Pharmaceuticals, Mallinckrodt Pharmaceuticals, Mylan N.V., Protega Pharmaceuticals LLC, Purdue Pharma LP, Quagen Pharma, and Teva Pharmaceuticals, Inc.